BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36291675)

  • 1. Digging into the 3D Structure Predictions of AlphaFold2 with Low Confidence: Disorder and Beyond.
    Bruley A; Mornon JP; Duprat E; Callebaut I
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A structural biology community assessment of AlphaFold2 applications.
    Akdel M; Pires DEV; Pardo EP; Jänes J; Zalevsky AO; Mészáros B; Bryant P; Good LL; Laskowski RA; Pozzati G; Shenoy A; Zhu W; Kundrotas P; Serra VR; Rodrigues CHM; Dunham AS; Burke D; Borkakoti N; Velankar S; Frost A; Basquin J; Lindorff-Larsen K; Bateman A; Kajava AV; Valencia A; Ovchinnikov S; Durairaj J; Ascher DB; Thornton JM; Davey NE; Stein A; Elofsson A; Croll TI; Beltrao P
    Nat Struct Mol Biol; 2022 Nov; 29(11):1056-1067. PubMed ID: 36344848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Random, de novo, and conserved proteins: How structure and disorder predictors perform differently.
    Middendorf L; Eicholt LA
    Proteins; 2024 Jun; 92(6):757-767. PubMed ID: 38226524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blind assessment of monomeric AlphaFold2 protein structure models with experimental NMR data.
    Li EH; Spaman LE; Tejero R; Janet Huang Y; Ramelot TA; Fraga KJ; Prestegard JH; Kennedy MA; Montelione GT
    J Magn Reson; 2023 Jul; 352():107481. PubMed ID: 37257257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling Flexible Protein Structure With AlphaFold2 and Crosslinking Mass Spectrometry.
    Manalastas-Cantos K; Adoni KR; Pfeifer M; Märtens B; Grünewald K; Thalassinos K; Topf M
    Mol Cell Proteomics; 2024 Mar; 23(3):100724. PubMed ID: 38266916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of AlphaFold2 and breakthroughs in overcoming its limitations.
    Wang L; Wen Z; Liu SW; Zhang L; Finley C; Lee HJ; Fan HS
    Comput Biol Med; 2024 Jun; 176():108620. PubMed ID: 38761500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpretable Atomistic Prediction and Functional Analysis of Conformational Ensembles and Allosteric States in Protein Kinases Using AlphaFold2 Adaptation with Randomized Sequence Scanning and Local Frustration Profiling.
    Raisinghani N; Alshahrani M; Gupta G; Tian H; Xiao S; Tao P; Verkhivker G
    bioRxiv; 2024 Feb; ():. PubMed ID: 38496487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of AI-based modeling on the accuracy of protein assembly prediction: Insights from CASP15.
    Ozden B; Kryshtafovych A; Karaca E
    Proteins; 2023 Dec; 91(12):1636-1657. PubMed ID: 37861057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AI-based AlphaFold2 significantly expands the structural space of the autophagy pathway.
    Malhotra N; Khatri S; Kumar A; Arun A; Daripa P; Fatihi S; Venkadesan S; Jain N; Thukral L
    Autophagy; 2023 Dec; 19(12):3201-3220. PubMed ID: 37516933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Template-free prediction of a new monotopic membrane protein fold and assembly by AlphaFold2.
    Gulsevin A; Han B; Porta JC; Mchaourab HS; Meiler J; Kenworthy AK
    Biophys J; 2023 Jun; 122(11):2041-2052. PubMed ID: 36352786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-evolution at protein-protein interfaces guides inference of stoichiometry of oligomeric protein complexes by de novo structure prediction.
    Kilian M; Bischofs IB
    Mol Microbiol; 2023 Nov; 120(5):763-782. PubMed ID: 37777474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tertiary structure assessment at CASP15.
    Simpkin AJ; Mesdaghi S; Sánchez Rodríguez F; Elliott L; Murphy DL; Kryshtafovych A; Keegan RM; Rigden DJ
    Proteins; 2023 Dec; 91(12):1616-1635. PubMed ID: 37746927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AlphaFold2 as a replacement for solution NMR structure determination of small proteins: Not so fast!
    Bonin JP; Aramini JM; Dong Y; Wu H; Kay LE
    J Magn Reson; 2024 Jun; 364():107725. PubMed ID: 38917639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AlphaFold2 structures template ligand discovery.
    Lyu J; Kapolka N; Gumpper R; Alon A; Wang L; Jain MK; Barros-Álvarez X; Sakamoto K; Kim Y; DiBerto J; Kim K; Tummino TA; Huang S; Irwin JJ; Tarkhanova OO; Moroz Y; Skiniotis G; Kruse AC; Shoichet BK; Roth BL
    bioRxiv; 2024 Mar; ():. PubMed ID: 38187536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biasing AlphaFold2 to predict GPCRs and kinases with user-defined functional or structural properties.
    Sala D; Hildebrand PW; Meiler J
    Front Mol Biosci; 2023; 10():1121962. PubMed ID: 36876042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CATH 2024: CATH-AlphaFlow Doubles the Number of Structures in CATH and Reveals Nearly 200 New Folds.
    Waman VP; Bordin N; Alcraft R; Vickerstaff R; Rauer C; Chan Q; Sillitoe I; Yamamori H; Orengo C
    J Mol Biol; 2024 Mar; ():168551. PubMed ID: 38548261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effector protein structures: a tale of evolutionary relationship.
    Kumar R; Acharya V
    Trends Plant Sci; 2023 Jul; 28(7):746-748. PubMed ID: 37127498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein domains of low sequence complexity-dark matter of the proteome.
    McKnight SL
    Genes Dev; 2024 Apr; 38(5-6):205-212. PubMed ID: 38503517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approximating conformational Boltzmann distributions with AlphaFold2 predictions.
    Brown BP; Stein RA; Meiler J; Mchaourab H
    bioRxiv; 2023 Aug; ():. PubMed ID: 37609301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPIscreenML: Structure-based screening for protein-protein interactions using AlphaFold.
    Mischley V; Maier J; Chen J; Karanicolas J
    bioRxiv; 2024 Apr; ():. PubMed ID: 38559274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.